Details for New Drug Application (NDA): 078420
✉ Email this page to a colleague
The generic ingredient in NABUMETONE is nabumetone. There are twenty drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the nabumetone profile page.
Summary for 078420
Tradename: | NABUMETONE |
Applicant: | Sciegen Pharms Inc |
Ingredient: | nabumetone |
Patents: | 0 |
Pharmacology for NDA: 078420
Mechanism of Action | Cyclooxygenase Inhibitors |
Suppliers and Packaging for NDA: 078420
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NABUMETONE | nabumetone | TABLET;ORAL | 078420 | ANDA | Medsource Pharmaceuticals | 45865-111 | 45865-111-60 | 60 TABLET in 1 BOTTLE (45865-111-60) |
NABUMETONE | nabumetone | TABLET;ORAL | 078420 | ANDA | A-S Medication Solutions | 50090-5294 | 50090-5294-0 | 60 TABLET in 1 BOTTLE (50090-5294-0) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
Approval Date: | Sep 24, 2008 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 750MG | ||||
Approval Date: | Sep 24, 2008 | TE: | AB | RLD: | No |
Complete Access Available with Subscription